NovoCure
NVCR
NVCR
326 hedge funds and large institutions have $9.95B invested in NovoCure in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 99 increasing their positions, 133 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 133
38% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 64
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
326
Holding in Top 10
4
Calls
$254M
Puts
$78.8M
Top Buyers
| 1 | +$118M | |
| 2 | +$114M | |
| 3 | +$83M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$79.7M |
| 5 |
Two Sigma Investments
New York
|
+$45.4M |
Top Sellers
| 1 | -$71.3M | |
| 2 | -$64.5M | |
| 3 | -$48.3M | |
| 4 |
DCP
Darsana Capital Partners
New York
|
-$33M |
| 5 |
CPC
Cookson Peirce & Co
Pittsburgh,
Pennsylvania
|
-$30.1M |